1. Home
  2. OOMA vs ALDX Comparison

OOMA vs ALDX Comparison

Compare OOMA & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

HOLD

Current Price

$11.49

Market Cap

332.9M

Sector

Technology

ML Signal

HOLD

Logo Aldeyra Therapeutics Inc.

ALDX

Aldeyra Therapeutics Inc.

HOLD

Current Price

$4.98

Market Cap

317.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OOMA
ALDX
Founded
2003
2004
Country
US
US
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
332.9M
317.7M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
OOMA
ALDX
Price
$11.49
$4.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$19.00
$9.50
AVG Volume (30 Days)
131.2K
723.7K
Earning Date
03-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$114,490,000.00
N/A
Revenue This Year
$7.80
N/A
Revenue Next Year
$19.21
$36.25
P/E Ratio
$128.67
N/A
Revenue Growth
9.53
N/A
52 Week Low
$9.79
$1.18
52 Week High
$15.09
$7.19

Technical Indicators

Market Signals
Indicator
OOMA
ALDX
Relative Strength Index (RSI) 47.29 45.73
Support Level $11.28 $4.91
Resistance Level $11.80 $5.56
Average True Range (ATR) 0.44 0.35
MACD -0.04 -0.06
Stochastic Oscillator 45.45 6.37

Price Performance

Historical Comparison
OOMA
ALDX

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: